NSE filing, NSE: STAR. Summary written from the filing by ALFA Finder's alert engine.
Strides Pharma Science Ltd: key numbers
- Share price
- ₹957.00
- Market cap
- ₹8,822 Cr
- Revenue (annual)
- ₹4,859 Cr
- Net profit (annual)
- ₹556.2 Cr
- P/E (TTM)
- 14.3×Sector 48.6×
- Promoter holding
- 29.00%+1.09% QoQ
- FII holding
- 27.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Strides Pharma Science Ltd
All →Strides Pharma Science Management Change
Strides Pharma seeks shareholder approval via postal ballot to appoint Mr. Biren Gabhawala as Independent Director for five years from November 1, 2026. Voting runs November 19 to December 19, 2026.
- Execution
- November 1, 2026 to October 31, 2031
Strides Pharma Science Earnings Call Transcript: Key Takeaways
Record Q2 revenue ₹1,430 Cr (+17% YoY), Ex-US overtakes US, but EBITDA margin fell to 17.6% on input costs; US aspiration slips beyond FY28.
Strides Pharma Science Management Change
Strides Pharma's board appointed Biren Gabhawala as Non-Executive Independent Director effective November 1, 2026, for five years. He is a Chartered Accountant with extensive audit and listed-company board experience.
- Execution
- Five-year term effective November 1, 2026
Strides Pharma Science Employee Stock Options
Strides Pharma allotted 7,500 equity shares to an employee exercising options under the Strides ESOP 2016 Plan. Paid-up capital rises to 92,180,214 shares.
Strides Pharma Science Investor Presentation: Key Takeaways
Q2FY27 revenue ₹14,297m (+17.1% YoY), EBITDA ₹2,509m (17.6% margin), reported PAT ₹1,341m (+2.0%). Ex-US revenue surpassed US for the first time; US ~$375m FY28 aspiration pushed beyond FY28.
Strides Pharma Science Results Update
Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.
Other annual general meeting announcements
All →Sky Gold and Diamonds Annual General Meeting
Shareholders passed the special resolution to raise funds through securities issuance at the 1st EOGM. Voting results and scrutinizer's report were filed under Regulation 44(3).
Affordable Robotic & Automation Annual General Meeting
Affordable Robotic seeks postal ballot approval for a Rs.200 Crore related-party limit, loan and guarantee authority, and borrowing powers. E-voting closes 19 December 2026.
Cera Sanitaryware Annual General Meeting
Cera Sanitaryware seeks postal ballot approval to re-appoint Vikram Somany as Chairman and MD, and Anandh Sundar as Independent Director. E-voting closes 18 December 2026.
OnEMI Technology Solutions Annual General Meeting
OnEMI Technology Solutions (Kissht) seeks shareholder approval via postal ballot to appoint Venkatadri Chandrasekaran as Non-Executive Independent Director for 3 years. E-voting closes 18 December 2026.
Senores Pharmaceuticals Annual General Meeting
Senores Pharmaceuticals announced that shareholders passed two special resolutions via postal ballot, re-appointing Swapnil Shah as MD and Chetan Shah as whole-time director. Voting closed on 17 November 2026 with resolutions passing at over 99% in favour.
United Polyfab Gujarat Annual General Meeting
United Polyfab Gujarat's EGM on 18 November 2026 considered three independent director appointments. Results are pending the scrutiniser's report.